Revolutionising Diabetes Detection with Home Testing

Digostics' revolutionary new testing platforms offer the world's first and only alternative to in-clinic testing for glucose intolerance by enabling the oral glucose tolerance test (OGTT) to be performed at home.

Our platforms offer the same level of accuracy as clinic tests but without any of the staffing requirements, risks of sample degradation and laboratory delays that often impact clinic testing capacity.

By removing the need for in-clinic tests, we provide a gateway to more extensive testing, faster results and unparalleled opportunities for earlier clinical intervention.

Medway NHS Foundation Trust latest maternity service to implement GTT@home

Digostics and Medway NHS Foundation Trust have announced a partnership to offer remote oral glucose tolerance testing to expectant mothers at risk of gestational diabetes mellitus (GDM).  This collaboration makes Medway the latest trust to adopt GTT@home.

“Our aim is to embrace digital technology so we can provide high quality care. The introduction of GTT@home is helping us to achieve this as our community midwives, who would have managed the workload associated with the traditional clinic-based test, can now focus more of their time and expertise on other critical areas of antenatal and postnatal care.”

Associate Director of Midwifery and Ambulatory Gynaecology at Medway NHS Foundation Trust

Medway NHS Foundation Trust latest maternity service to implement GTT@home

“Our aim is to embrace digital technology so we can provide high quality care. The introduction of GTT@home is helping us to achieve this as our community midwives, who would have managed the workload associated with the traditional clinic-based test, can now focus more of their time and expertise on other critical areas of antenatal and postnatal care.”

Associate Director of Midwifery and Ambulatory Gynaecology at Medway NHS Foundation Trust